Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 25 | $5,646,489 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 05 Nov 2024 09:04 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Nov 2024 | Sale | 34,943 | 31.254 | 1,092,109 | D |
| 05 Nov 2024 09:04 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Nov 2024 | Sale | 15,481 | 32.267 | 499,525 | D |
| 05 Nov 2024 09:04 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Nov 2024 | Sale | 292 | 32.937 | 9,618 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 14 Oct 2024 | Sale | 40,000 | 30.152 | 1,206,080 | D |
| 03 Oct 2024 20:09 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Oct 2024 | Sale | 10,000 | 28.177 | 281,770 | D |
| 13 Sep 2024 17:16 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 10 Sep 2024 | Sale | 568 | 26.18 | 14,870 | D |
| 05 Sep 2024 16:08 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Sep 2024 | Sale | 1,290 | 27.576 | 35,573 | D |
| 05 Sep 2024 16:08 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Sep 2024 | Sale | 3,710 | 26.419 | 98,014 | D |
| 02 Aug 2024 21:32 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Aug 2024 | Sale | 1,969 | 27.23 | 53,616 | D |
| 02 Aug 2024 21:32 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Aug 2024 | Sale | 3,031 | 26.44 | 80,140 | D |
| 02 Jul 2024 18:55 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Jul 2024 | Sale | 5,000 | 23.404 | 117,020 | D |
| 13 Jun 2024 18:13 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 11 Jun 2024 | Sale | 2,516 | 22.641 | 56,965 | D |
| 05 Jun 2024 17:05 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Jun 2024 | Sale | 5,000 | 19.288 | 96,440 | D |
| 02 May 2024 21:07 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 May 2024 | Sale | 5,000 | 20.1499 | 100,750 | D |
| 03 Apr 2024 18:55 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Apr 2024 | Sale | 400 | 25.025 | 10,010 | D |
| 03 Apr 2024 18:55 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Apr 2024 | Sale | 4,600 | 24.3267 | 111,903 | D |
| 15 Mar 2024 16:42 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 13 Mar 2024 | Sale | 651 | 28.33 | 18,443 | D |
| 29 Dec 2023 20:30 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 27 Dec 2023 | Sale | 5,414 | 24 | 129,936 | D |
| 18 Dec 2023 20:39 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 14 Dec 2023 | Sale | 543 | 20.76 | 11,273 | D |
| 21 Nov 2023 17:30 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 17 Nov 2023 | Sale | 30,000 | 14.6753 | 440,259 | D |
| 04 Oct 2023 20:33 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 02 Oct 2023 | Sale | 490 | 51.1 | 25,039 | D |
| 25 Sep 2023 20:28 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 13 Sep 2023 | Sale | 562 | 50.34 | 28,291 | D |
| 15 Jun 2023 21:35 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 13 Jun 2023 | Sale | 538 | 55.16 | 29,676 | D |
| 05 Jan 2023 17:56 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Jan 2023 | Sale | 8,777 | 54.6383 | 479,560 | D |
| 28 Dec 2022 18:30 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 27 Dec 2022 | Sale | 12,500 | 49.5687 | 619,609 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)